We've found
12,214
archived clinical trials in
Women's Studies
We've found
12,214
archived clinical trials in
Women's Studies
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)
Updated: 9/30/2013
Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease
Updated: 9/30/2013
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease.
Status: Enrolling
Updated: 9/30/2013
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease
Updated: 9/30/2013
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease.
Status: Enrolling
Updated: 9/30/2013
Click here to add this to my saved trials
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Click here to add this to my saved trials
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Click here to add this to my saved trials
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Click here to add this to my saved trials
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Click here to add this to my saved trials
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Click here to add this to my saved trials
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Click here to add this to my saved trials
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Open-Label Extension Study to ZPE-202
Updated: 10/10/2013
A Phase 2, Multi-Center, Open-Label Extension Study to Evaluate the Safety and Efficacy of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Endometriosis
Status: Enrolling
Updated: 10/10/2013
Click here to add this to my saved trials
The Purpose of This Study is to Look at Pelvic Support Problems, Also Commonly Known as Pelvic Organ Prolapse
Updated: 10/15/2013
FemmeJock: A Pilot Study to Assess Patient Satisfaction and Improvement of Pelvic Floor Symptoms Using a Pelvic Floor Support Girdle in Women With Uterovaginal Prolapse.
Status: Enrolling
Updated: 10/15/2013
The Purpose of This Study is to Look at Pelvic Support Problems, Also Commonly Known as Pelvic Organ Prolapse
Updated: 10/15/2013
FemmeJock: A Pilot Study to Assess Patient Satisfaction and Improvement of Pelvic Floor Symptoms Using a Pelvic Floor Support Girdle in Women With Uterovaginal Prolapse.
Status: Enrolling
Updated: 10/15/2013
Click here to add this to my saved trials
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin
Updated: 10/21/2013
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin in Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 10/21/2013
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin
Updated: 10/21/2013
Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin in Women at High Risk for Breast Cancer
Status: Enrolling
Updated: 10/21/2013
Click here to add this to my saved trials
Exercise in Pregnancy for Reduction of Blood Pressure in Obese Patients
Updated: 10/24/2013
Exercise Intervention in Pregnancy for Reduction of Blood Pressure in Obese Gravidas
Status: Enrolling
Updated: 10/24/2013
Exercise in Pregnancy for Reduction of Blood Pressure in Obese Patients
Updated: 10/24/2013
Exercise Intervention in Pregnancy for Reduction of Blood Pressure in Obese Gravidas
Status: Enrolling
Updated: 10/24/2013
Click here to add this to my saved trials
a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy.
Updated: 10/26/2013
A Case Study to Evaluate Adhesion Risk in Fertility Patients' Post Laparoscopic Myomectomy Utilizing Vloc Suture.
Status: Enrolling
Updated: 10/26/2013
a Study to Evaluate Adhesion Risk in Fertility Patients' Status Post Laparoscopic Myomectomy.
Updated: 10/26/2013
A Case Study to Evaluate Adhesion Risk in Fertility Patients' Post Laparoscopic Myomectomy Utilizing Vloc Suture.
Status: Enrolling
Updated: 10/26/2013
Click here to add this to my saved trials
ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study
Updated: 10/28/2013
Indocyanine Green Angiography-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities.
Status: Enrolling
Updated: 10/28/2013
ICG-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities: A Pilot Study
Updated: 10/28/2013
Indocyanine Green Angiography-Guided Photodynamic Therapy for Treatment of Retinal Capillary Abnormalities.
Status: Enrolling
Updated: 10/28/2013
Click here to add this to my saved trials
Efficacy of Gralise® for Chronic Pelvic Pain
Updated: 10/29/2013
Efficacy of Gralise® for Chronic Pelvic Pain
Status: Enrolling
Updated: 10/29/2013
Efficacy of Gralise® for Chronic Pelvic Pain
Updated: 10/29/2013
Efficacy of Gralise® for Chronic Pelvic Pain
Status: Enrolling
Updated: 10/29/2013
Click here to add this to my saved trials
Intracutaneous Sterile Water Injections
Updated: 10/31/2013
Intracutaneous Sterile Water Injection as an Adjunct to Neuraxial Labor Analgesia: A Randomized Controlled Trial
Status: Enrolling
Updated: 10/31/2013
Intracutaneous Sterile Water Injections
Updated: 10/31/2013
Intracutaneous Sterile Water Injection as an Adjunct to Neuraxial Labor Analgesia: A Randomized Controlled Trial
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Same-day Dilapan-S With Adjunctive Misoprostol
Updated: 10/31/2013
Dilapan-S With Adjunctive Misoprostol for Same-day Second Trimester Dilation and Evacuation: A Randomized, Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 10/31/2013
Same-day Dilapan-S With Adjunctive Misoprostol
Updated: 10/31/2013
Dilapan-S With Adjunctive Misoprostol for Same-day Second Trimester Dilation and Evacuation: A Randomized, Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Same-day Dilapan-S With Adjunctive Misoprostol
Updated: 10/31/2013
Dilapan-S With Adjunctive Misoprostol for Same-day Second Trimester Dilation and Evacuation: A Randomized, Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 10/31/2013
Same-day Dilapan-S With Adjunctive Misoprostol
Updated: 10/31/2013
Dilapan-S With Adjunctive Misoprostol for Same-day Second Trimester Dilation and Evacuation: A Randomized, Double-Blind, Placebo-Controlled Trial
Status: Enrolling
Updated: 10/31/2013
Click here to add this to my saved trials
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
Updated: 11/4/2013
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
Status: Enrolling
Updated: 11/4/2013
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
Updated: 11/4/2013
Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders
Status: Enrolling
Updated: 11/4/2013
Click here to add this to my saved trials
Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus
Updated: 11/5/2013
Development and Evaluation of a Clinic-Based Screening and Brief Intervention for Changing Behaviors Related to Cytomegalovirus Transmission in Pregnant Women
Status: Enrolling
Updated: 11/5/2013
Clinical Trial of Behavioral Modification to Prevent Congenital Cytomegalovirus
Updated: 11/5/2013
Development and Evaluation of a Clinic-Based Screening and Brief Intervention for Changing Behaviors Related to Cytomegalovirus Transmission in Pregnant Women
Status: Enrolling
Updated: 11/5/2013
Click here to add this to my saved trials
Gene Expression in Cumulus Cells to Predict Pregnancy
Updated: 11/6/2013
The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.
Status: Enrolling
Updated: 11/6/2013
Gene Expression in Cumulus Cells to Predict Pregnancy
Updated: 11/6/2013
The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.
Status: Enrolling
Updated: 11/6/2013
Click here to add this to my saved trials
Gene Expression in Cumulus Cells to Predict Pregnancy
Updated: 11/6/2013
The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.
Status: Enrolling
Updated: 11/6/2013
Gene Expression in Cumulus Cells to Predict Pregnancy
Updated: 11/6/2013
The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.
Status: Enrolling
Updated: 11/6/2013
Click here to add this to my saved trials
Gene Expression in Cumulus Cells to Predict Pregnancy
Updated: 11/6/2013
The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.
Status: Enrolling
Updated: 11/6/2013
Gene Expression in Cumulus Cells to Predict Pregnancy
Updated: 11/6/2013
The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.
Status: Enrolling
Updated: 11/6/2013
Click here to add this to my saved trials
Gene Expression in Cumulus Cells to Predict Pregnancy
Updated: 11/6/2013
The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.
Status: Enrolling
Updated: 11/6/2013
Gene Expression in Cumulus Cells to Predict Pregnancy
Updated: 11/6/2013
The Predictive Value of a Gene Expression Signature in Cumulus Cells Indicative of Embryo Implantation.
Status: Enrolling
Updated: 11/6/2013
Click here to add this to my saved trials
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Click here to add this to my saved trials
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Click here to add this to my saved trials
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Click here to add this to my saved trials
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Click here to add this to my saved trials
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Click here to add this to my saved trials
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine
Updated: 11/12/2013
A Multi-Center, Non-Randomized Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood and Urine of Women With a Singleton Pregnancy and a Previous Singleton Spontaneous Preterm Delivery
Status: Enrolling
Updated: 11/12/2013
Click here to add this to my saved trials
Effects of Analgesic Techniques on Duration of Spontaneously Laboring Patients
Updated: 11/12/2013
A Randomized Trial of the Impact of Three Labor Analgesia Techniques on Labor Duration in Spontaneously Laboring Nulliparous Parturients
Status: Enrolling
Updated: 11/12/2013
Effects of Analgesic Techniques on Duration of Spontaneously Laboring Patients
Updated: 11/12/2013
A Randomized Trial of the Impact of Three Labor Analgesia Techniques on Labor Duration in Spontaneously Laboring Nulliparous Parturients
Status: Enrolling
Updated: 11/12/2013
Click here to add this to my saved trials
Effects of Analgesic Techniques on Duration of Labor for Induction Patients
Updated: 11/12/2013
A Randomized Trial of the Impact of Three Labor Analgesia Techniques on Labor Duration in Nulliparous Labor Inductions
Status: Enrolling
Updated: 11/12/2013
Effects of Analgesic Techniques on Duration of Labor for Induction Patients
Updated: 11/12/2013
A Randomized Trial of the Impact of Three Labor Analgesia Techniques on Labor Duration in Nulliparous Labor Inductions
Status: Enrolling
Updated: 11/12/2013
Click here to add this to my saved trials
Effects of Ospemifene on Pelvic Vascularity and Blood Flow
Updated: 12/9/2013
The Effects of Vaginal Ospemifene on Pelvic Organ Vascularity and Blood Flow in Postmenopausal Women
Status: Enrolling
Updated: 12/9/2013
Effects of Ospemifene on Pelvic Vascularity and Blood Flow
Updated: 12/9/2013
The Effects of Vaginal Ospemifene on Pelvic Organ Vascularity and Blood Flow in Postmenopausal Women
Status: Enrolling
Updated: 12/9/2013
Click here to add this to my saved trials
Optimal Timing of Cord Clamping in Preterm Pregnancy Following Vaginal or Cesarean Delivery
Updated: 12/11/2013
Timing of Umbilical Cord Clamping After Vaginal or Cesarean Preterm Birth
Status: Enrolling
Updated: 12/11/2013
Optimal Timing of Cord Clamping in Preterm Pregnancy Following Vaginal or Cesarean Delivery
Updated: 12/11/2013
Timing of Umbilical Cord Clamping After Vaginal or Cesarean Preterm Birth
Status: Enrolling
Updated: 12/11/2013
Click here to add this to my saved trials
Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer
Updated: 12/16/2013
Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer
Status: Enrolling
Updated: 12/16/2013
Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer
Updated: 12/16/2013
Tumor Perfusion and Hypoxia Assessed by DCE-MRI and 18F-FMISO PET as Biomarkers of Treatment Response in Cervical Cancer
Status: Enrolling
Updated: 12/16/2013
Click here to add this to my saved trials
Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia
Updated: 12/30/2013
Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia
Status: Enrolling
Updated: 12/30/2013
Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia
Updated: 12/30/2013
Comparison of Random Spot Urine Protein:Creatinine Ratio to 24-Hour Timed Urine Protein Collection in the Evaluation of Preeclampsia
Status: Enrolling
Updated: 12/30/2013
Click here to add this to my saved trials
Efficacy and Satisfaction Comparing Two Braces in the Treatment of Developmental Dysplasia of the Hip (DDH) in Infants
Updated: 12/31/2013
Efficacy and Satisfaction Comparing Two Braces in the Treatment of DDH in Infants: A Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/2013
Efficacy and Satisfaction Comparing Two Braces in the Treatment of Developmental Dysplasia of the Hip (DDH) in Infants
Updated: 12/31/2013
Efficacy and Satisfaction Comparing Two Braces in the Treatment of DDH in Infants: A Randomized Clinical Trial
Status: Enrolling
Updated: 12/31/2013
Click here to add this to my saved trials
Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women
Updated: 1/2/2014
Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women
Status: Enrolling
Updated: 1/2/2014
Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women
Updated: 1/2/2014
Effectiveness of Manual Physical Therapy to Improve Endocrine Levels in Women
Status: Enrolling
Updated: 1/2/2014
Click here to add this to my saved trials